galactosamine has been researched along with krn 7000 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, K; Arakawa, T; Fujii, H; Fujiwara, H; Ikarashi, Y; Ikemoto, M; Kaneda, K; Kawakita, N; Kitada, T; Kobayashi, S; Kronenberg, M; Mitchell, K; Nakajima, Y; Nakanishi, K; Seki, S; Taniguchi, M; Tsutsui, H | 1 |
Badamtseren, B; Haque, A; Koide, N; Komatsu, T; Morikawa, A; Naiki, Y; Odkhuu, E; Yokochi, T; Yoshida, T | 1 |
2 other study(ies) available for galactosamine and krn 7000
Article | Year |
---|---|
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Galactosamine; Galactosylceramides; In Situ Nick-End Labeling; Interferon-gamma; Killer Cells, Natural; Liver; Liver Diseases; Mice; Mice, Knockout; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2005 |
Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with D-galactosamine sensitization and the involvement of fewer natural killer T cells.
Topics: Animals; Caspase 3; Disease Models, Animal; Disease Susceptibility; Endotoxemia; Galactosamine; Galactose; Galactosylceramides; Immunologic Factors; Interferon-gamma; Lipopolysaccharides; Liver; Lymphocyte Activation; Mice; Mice, Inbred Strains; Natural Killer T-Cells; Nitric Oxide; Nitric Oxide Synthase Type II; Receptors, Antigen, T-Cell, alpha-beta | 2012 |